Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,684 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.
Parmigiani G, Berry D, Aguilar O. Parmigiani G, et al. Among authors: berry d. Am J Hum Genet. 1998 Jan;62(1):145-58. doi: 10.1086/301670. Am J Hum Genet. 1998. PMID: 9443863 Free PMC article.
Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.
Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BJ, Iglehart JD. Marks JR, et al. Among authors: berry d. Ann Surg. 1994 Apr;219(4):332-41. doi: 10.1097/00000658-199404000-00002. Ann Surg. 1994. PMID: 7909221 Free PMC article.
Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.
Claus EB, Schildkraut J, Iversen ES Jr, Berry D, Parmigiani G. Claus EB, et al. Among authors: berry d. J Natl Cancer Inst. 1998 Dec 2;90(23):1824-9. doi: 10.1093/jnci/90.23.1824. J Natl Cancer Inst. 1998. PMID: 9839523
Overestimation of hereditary breast cancer risk.
Iglehart JD, Miron A, Rimer BK, Winer EP, Berry D, Shildkraut MJ. Iglehart JD, et al. Among authors: berry d. Ann Surg. 1998 Sep;228(3):375-84. doi: 10.1097/00000658-199809000-00010. Ann Surg. 1998. PMID: 9742920 Free PMC article.
Cost-effectiveness of treatment of early stage endometrial cancer.
Ashih H, Gustilo-Ashby T, Myers ER, Andrews J, Clarke-Pearson DL, Berry D, Berchuck A. Ashih H, et al. Among authors: berry d. Gynecol Oncol. 1999 Aug;74(2):208-16. doi: 10.1006/gyno.1999.5427. Gynecol Oncol. 1999. PMID: 10419733
Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
Laughlin MJ, McGaughey DS, Crews JR, Chao NJ, Rizzieri D, Ross M, Gockerman J, Cirrincione C, Berry D, Mills L, Defusco P, LeGrand S, Peters WP, Vredenburgh JJ. Laughlin MJ, et al. Among authors: berry d. J Clin Oncol. 1998 Mar;16(3):1008-12. doi: 10.1200/JCO.1998.16.3.1008. J Clin Oncol. 1998. PMID: 9508184
Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, Dewhirst M, Greenberg C. Blackwell K, et al. Among authors: berry d. J Clin Oncol. 2000 Feb;18(3):600-8. doi: 10.1200/JCO.2000.18.3.600. J Clin Oncol. 2000. PMID: 10653875 Clinical Trial.
PURPOSE: To investigate the relationship between preoperative plasma D-dimer levels and extent of tumor involvement in operable breast cancer patients. ...Quantitative D-dimer levels were highly correlated with clinical stage grouping (analysis of variance test; P = …
PURPOSE: To investigate the relationship between preoperative plasma D-dimer levels and extent of tumor involvement in operable breas …
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).
Kimmick GG, Cirrincione C, Duggan DB, Bhalla K, Robert N, Berry D, Norton L, Lemke S, Henderson IC, Hudis C, Winer E; Cancer and Leukemia Group B. Kimmick GG, et al. Among authors: berry d. Breast Cancer Res Treat. 2009 Feb;113(3):479-90. doi: 10.1007/s10549-008-9943-2. Epub 2008 Feb 28. Breast Cancer Res Treat. 2009. PMID: 18306034 Free PMC article. Clinical Trial.
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.
Rizzieri DA, Vredenburgh JJ, Jones R, Ross M, Shpall EJ, Hussein A, Broadwater G, Berry D, Petros WP, Gilbert C, Affronti ML, Coniglio D, Rubin P, Elkordy M, Long GD, Chao NJ, Peters WP. Rizzieri DA, et al. Among authors: berry d. J Clin Oncol. 1999 Oct;17(10):3064-74. doi: 10.1200/JCO.1999.17.10.3064. J Clin Oncol. 1999. PMID: 10506601 Clinical Trial.
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.
Peters KG, Coogan A, Berry D, Marks J, Iglehart JD, Kontos CD, Rao P, Sankar S, Trogan E. Peters KG, et al. Among authors: berry d. Br J Cancer. 1998;77(1):51-6. doi: 10.1038/bjc.1998.8. Br J Cancer. 1998. PMID: 9459145 Free PMC article.
2,684 results
Jump to page
Feedback